116 related articles for article (PubMed ID: 37556965)
1. Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma.
Jiang D; Song Q; Zhang F; Xu C; Li X; Zeng H; Su J; Huang J; Xu Y; Lu S; Hou Y
Cancer Genet; 2023 Nov; 278-279():1-8. PubMed ID: 37556965
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma.
Wang MT; Chen G; An SJ; Chen ZH; Huang ZM; Xiao P; Ben XS; Xie Z; Chen SL; Luo DL; Tang JM; Lin JY; Zhang XC; Wu YL
Dis Esophagus; 2012; 25(7):664-70. PubMed ID: 22150974
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma.
Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y
Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643
[TBL] [Abstract][Full Text] [Related]
4. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
5. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.
Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y
Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
7. Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma.
Takeshita H; Ichikawa D; Komatsu S; Tsujiura M; Kosuga T; Deguchi K; Konishi H; Morimura R; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Br J Cancer; 2010 Apr; 102(9):1378-83. PubMed ID: 20389301
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.
Sunpaweravong P; Sunpaweravong S; Puttawibul P; Mitarnun W; Zeng C; Barón AE; Franklin W; Said S; Varella-Garcia M
J Cancer Res Clin Oncol; 2005 Feb; 131(2):111-9. PubMed ID: 15672286
[TBL] [Abstract][Full Text] [Related]
9. HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population.
Rong L; Wang B; Guo L; Liu X; Wang B; Ying J; Xue L; Lu N
Diagn Pathol; 2020 Mar; 15(1):27. PubMed ID: 32209107
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma.
Jiang D; Li X; Wang H; Shi Y; Xu C; Lu S; Huang J; Xu Y; Zeng H; Su J; Hou Y; Tan L
BMC Cancer; 2015 May; 15():377. PubMed ID: 25953424
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y
Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma.
Yu Z; Wang H; Song Q; Huang J; Xu J; Su J; Wang H; Tan L; Wang X; Jiang Z; Chen W; Jiang D; Hou Y
J Cancer Res Clin Oncol; 2021 Oct; 147(10):3113-3121. PubMed ID: 33963905
[TBL] [Abstract][Full Text] [Related]
13. CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response.
Seiler R; Thalmann GN; Rotzer D; Perren A; Fleischmann A
Mod Pathol; 2014 Jan; 27(1):87-95. PubMed ID: 23887292
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
[TBL] [Abstract][Full Text] [Related]
15. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract][Full Text] [Related]
16. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas.
Miyamoto R; Uzawa N; Nagaoka S; Hirata Y; Amagasa T
Oral Oncol; 2003 Sep; 39(6):610-8. PubMed ID: 12798405
[TBL] [Abstract][Full Text] [Related]
18. Amplification and overexpression of
Hu X; Moon JW; Li S; Xu W; Wang X; Liu Y; Lee JY
Int J Med Sci; 2016; 13(11):868-874. PubMed ID: 27877079
[TBL] [Abstract][Full Text] [Related]
19. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.
J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
